makereceptor gui of oedocking 3.5.0.4 (OpenEye Scientific Software Inc)
90
Structured Review
OpenEye Scientific Software Inc
makereceptor gui of oedocking 3.5.0.4
Makereceptor Gui Of Oedocking 3.5.0.4, supplied by OpenEye Scientific Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/makereceptor+gui+of+oedocking+3%2E5%2E0%2E4/makereceptor+gui+of+oedocking+3+5+0+4/pm38914798-90-10-13
Average 90 stars, based on 1 article reviews
Makereceptor Gui Of Oedocking 3.5.0.4, supplied by OpenEye Scientific Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/makereceptor+gui+of+oedocking+3%2E5%2E0%2E4/makereceptor+gui+of+oedocking+3+5+0+4/pm38914798-90-10-13
Average 90 stars, based on 1 article reviews
makereceptor gui of oedocking 3.5.0.4 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies. Article Snippet: In a search for new drug candidates for one of the neglected tropical diseases, leishmaniasis, twenty quinolineisatin hybrids were synthesized and tested for their in vitro antileishmanial activity against Leishmania major strain.. All the synthesized compounds showed promising in vitro activity against the promastigote form in a low micromolar range (IC50 = 0.5084–5.9486 μM) superior to the reference miltefosine (IC50 = 7.8976 μM).. All the target compounds were then tested against the intracellular amastigote form and showed promising inhibition effects (IC50 = 0.60442–8.2948 μM versus 8.08 μM for miltefosine). Article Title: Discovery of new pyridine-quinoline hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase 3/7 activation capabilities Article Snippet: The PDB structures were prepared using Article Title: Inhibitory Effect of Two Carbonic Anhydrases Inhibitors on the Activity of Major Cytochrome P450 Enzymes. Article Snippet: Background and Objectives Both AW-9A (coumarin derivative) and WES-1 (sulfonamide derivative) were designed and synthesized as potential selective carbonic anhydrase inhibitors and were tested for anticancer activity.. This study was undertaken to investigate their potential inhibitory effects on the major human cytochrome P450 (CYP) drug-metabolizing enzymes.. Methods Specific CYP probe substrates and validated analytical methods were used to measure the activity of the tested CYP enzymes. |